We are live on
!
Find out more
CCI
Columbus Circle Investors Portfolio holdings
AUM
$2.28B
1-Year Est. Return
135.57%
This Fund
S&P 500
This Quarter
Est. Return
+12.29%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
–
AUM
$14.6B
AUM Growth
+$529M
(+3.7%)
Cap. Flow
-$730M
Cap. Flow
% of AUM
-4.98%
Top 10 Holdings %
Top 10 Hldgs %
19.19%
Holding
388
New
75
Increased
92
Reduced
120
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$100M |
| 2 |
McKesson
MCK
|
+$96.3M |
| 3 |
Deckers Outdoor
DECK
|
+$91.8M |
| 4 |
STJ
St Jude Medical
STJ
|
+$83.4M |
| 5 |
CME Group
CME
|
+$82.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$194M |
| 2 |
Union Pacific
UNP
|
+$159M |
| 3 |
Goldman Sachs
GS
|
+$136M |
| 4 |
PPLI
People Inc
PPLI
|
+$110M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.86% |
| 2 | Consumer Discretionary | 16.59% |
| 3 | Technology | 15.02% |
| 4 | Industrials | 12.03% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Vince Holding Corp
VNCE
$86.8M
| $12.2M | 0.08% |
+39,823
| New | +$11.9M |
|
|
NPSP
202
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $12M | 0.08% |
+396,086
| New | +$10.9M |
|
|
EGN
203
DELISTED
Energen
EGN
| $11.9M | 0.08% |
+167,936
| New | +$12.6M |
|
204
Align Technology
ALGN
$12.3B
| $11.8M | 0.08% |
206,506
+28,273
| +16% | +$1.52M |
|
205
Danaher
DHR
$144B
| $11.7M | 0.08% |
225,509
-93,951
| -29% | -$4.62M |
|
206
Johnson & Johnson
JNJ
$625B
| $11.7M | 0.08% |
127,421
-118,458
| -48% | -$10.9M |
|
207
Vitamin Cottage Natural Grocers
NGVC
$654M
| $11.5M | 0.08% |
270,378
-105,584
| -28% | -$4.06M |
|
208
SPS Commerce
SPSC
$2.64B
| $11.4M | 0.08% |
350,486
+118,240
| +51% | +$4.02M |
|
209
Matrix Service
MTRX
$335M
| $11.4M | 0.08% |
467,550
+74,890
| +19% | +$1.6M |
|
210
Teva Pharmaceuticals
TEVA
$41.2B
| $11.4M | 0.08% |
+284,970
| New | +$11.2M |
|
211
Employers Holdings
EIG
$889M
| $10.9M | 0.07% |
345,450
+8,490
| +3% | +$263K |
|
212
Acadia Pharmaceuticals
ACAD
$5.03B
| $10.8M | 0.07% |
+431,014
| New | +$10.2M |
|
|
YOKU
213
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $10.6M | 0.07% |
+349,550
| New | +$10M |
|
|
OMED
214
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $10.2M | 0.07% |
+345,493
| New | +$6.33M |
|
215
Best Buy
BBY
$17.3B
| $10.1M | 0.07% |
+253,432
| New | +$10.4M |
|
216
Bread Financial
BFH
$4.38B
| $10M | 0.07% |
47,832
-179,522
| -79% | -$34.3M |
|
217
Revvity
RVTY
$12.8B
| $9.88M | 0.07% |
239,624
-151,614
| -39% | -$5.8M |
|
|
FINL
218
DELISTED
Finish Line
FINL
| $9.66M | 0.07% |
+342,906
| New | +$8.74M |
|
219
UnitedHealth
UNH
$370B
| $9.56M | 0.07% |
+126,985
| New | +$9.12M |
|
|
COV
220
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $9.46M | 0.06% |
138,976
-316,096
| -69% | -$20.6M |
|
221
Novartis
NVS
$297B
| $9.42M | 0.06% |
130,748
-146,672
| -53% | -$10.2M |
|
222
Invesco
IVZ
$13.9B
| $9.39M | 0.06% |
258,053
-347,802
| -57% | -$11.8M |
|
223
Broadcom
AVGO
$2.04T
| $9.31M | 0.06% |
1,759,790
-1,277,170
| -42% | -$5.88M |
|
224
Flowserve
FLS
$10.2B
| $9.18M | 0.06% |
+116,469
| New | +$8.07M |
|
|
TEAR
225
DELISTED
TearLab Corporation
TEAR
| $9.07M | 0.06% |
97,067
-25,756
| -21% | -$2.57M |
|
Similar funds
SWM
LCM
HCMNY
BII
HCM
DBC
DK
AVAX
Columbus Circle Investors's Q4 2013 Portfolio in Review
As of Q4 2013, Columbus Circle Investors held 388 positions worth $14.6B, up 3.7% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Columbus Circle Investors withdrew a net $730M in Q4 2013, closing 100 positions and reducing 120 holdings. Its most notable exit was Cisco, an estimated $194M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Columbus Circle Investors opened a new position in Bristol-Myers Squibb worth $105M.
- Columbus Circle Investors's largest Q4 2013 buy was Bristol-Myers Squibb: 1,970,174 shares worth $105M.
- Columbus Circle Investors added most to Morgan Stanley in Q4 2013, an estimated $74.7M increase.
- Columbus Circle Investors's biggest Q4 2013 reduction was Capri Holdings, cutting an estimated $77.6M.
- Columbus Circle Investors fully exited Cisco in Q4 2013, selling an estimated $194M.
- Columbus Circle Investors's ten largest holdings make up 19% of its $14.6B portfolio in Q4 2013.
- Columbus Circle Investors opened 75 new positions and closed 100 in Q4 2013.
- Columbus Circle Investors's portfolio value rose 3.7% quarter-over-quarter to $14.6B.
Based on Columbus Circle Investors's 13F filing for Q4 2013, filed 5 Feb 2014.